Finding Your Digital Opinion Leaders: Identification, Scoring, and Prioritization Frameworks 

July 2 | 17:00 CET | 60 minutes

Most pharma teams agree that Digital Opinion Leaders matter. Ask how those DOLs were selected, though, and the answers will vary.

Some names come from internal recommendations. Others are discovered through LinkedIn searches, conference observations, agency suggestions, or social listening tools. Different teams apply different criteria. Follower counts can outweigh scientific credibility. Active creators receive attention while influential specialists with smaller audiences may never appear on a shortlist.

As a consequence, you have a process that can be tough to repeat, explain, or scale. And that is a problem, as healthcare professionals spend more and more time discussing research, treatment experiences, and clinical practice online.

A majority of physicians now use social media for professional purposes, whether to follow medical news, learn from peers, or participate in clinical discussions. Hence, your task now is more than finding active voices, but genuinely influential ones.

Join Pavlo Klymenko, Head of Omnichannel at Viseven, moderated by Anna Zolotnytska, Head of Strategic PR & Communications at Viseven, on July 2, 17:00 CET for a practical discussion on how to identify, evaluate, and prioritize DOLs using a structured methodology.

During the session, you’ll learn:

• What actually makes someone a DOL within a specific therapy area
• How to build a DOL candidate list using platform data, social listening tools, and peer network signals
• How to assess candidates across reach, resonance, relevance, and scientific credibility
• How to validate and prioritize DOLs before engagement begins
• How to create a process that can stand up to Medical, Legal, and Commercial review

Whether you’re launching a DOL program for the first time or refining an existing approach, this webinar will provide practical frameworks you can apply immediately.

Reserve your seat and bring your questions for the live Q&A. See you there!